Immune-related fulminant adverse events induced by nivolumab:one case report
After an 8-month therapy of nivolumab,one patient of right lung carcinoma had a rare outbreak of multi-system immune adverse reactions such as immune myocardi-tis,immune encephalitis,immune pneumonia,immune hypo-pituitarism,immune thrombocytopenia and immune hepatitis.The clinical characteristics of this case were analyzed along with the similarities and differences with other multi-system immune-related adverse events due to immune checkpoint inhibitors.
NETL
NSTL
万方数据
